vendex and Coronary-Restenosis

vendex has been researched along with Coronary-Restenosis* in 1 studies

Other Studies

1 other study(ies) available for vendex and Coronary-Restenosis

ArticleYear
Drug eluting coronary stent: in vitro evaluation of magnet resonance safety at 3 Tesla.
    Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2005, Volume: 7, Issue:2

    To evaluate MR safety at 3 Tesla for a drug eluting coronary stent.. A drug eluting coronary stent (Endeavor, cobalt alloy, Medtronic Vascular, Santa Rosa, CA) was evaluated for magnetic field interactions, heating, and artifacts at 3 Tesla. MRI-related heating was assessed with the stent in a gelled saline-filled phantom using a transmit/received RF body coil with a whole body averaged SAR of 2.0 W/kg. Artifacts were characterized using T1-weighted, spin echo, and gradient echo pulse sequences.. The stent exhibited minor magnetic field interactions that will not cause migration. Heating was not substantial (+0.5 degrees C). Artifacts may create a problem if the area of interest is in the same area or close to the stent (e.g., for a T1-weighted, spin echo pulse sequence, within approximately 16 mm; for a gradient echo pulse sequence, within approximately 23 mm). Conclusion. The findings indicated that it would be safe for a patient with this cobalt alloy-based, drug-eluting coronary stent to undergo MRI at 3 Tesla or less. Importantly, because of the relative lack of magnetic field interactions, MRI may be performed immediately after implantation.

    Topics: Artifacts; Coated Materials, Biocompatible; Coronary Restenosis; Drug Delivery Systems; Electromagnetic Fields; Equipment Safety; Hot Temperature; Humans; Magnetic Resonance Imaging; Materials Testing; Phantoms, Imaging; Stents; Temperature; Torque

2005